70 related articles for article (PubMed ID: 16288728)
1. Differential effects of TGF-beta1 on telomerase activity in thyroid carcinoma cell lines.
Lindkvist A; Franzén A; Ren ZP; Heldin NE; Paulsson-Karlsson Y
Biochem Biophys Res Commun; 2005 Dec; 338(3):1625-33. PubMed ID: 16288728
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol 3-kinase/Akt pathway is involved in transforming growth factor-beta1-induced phenotypic modulation of 10T1/2 cells to smooth muscle cells.
Lien SC; Usami S; Chien S; Chiu JJ
Cell Signal; 2006 Aug; 18(8):1270-8. PubMed ID: 16310342
[TBL] [Abstract][Full Text] [Related]
3. Genistein represses telomerase activity via both transcriptional and posttranslational mechanisms in human prostate cancer cells.
Jagadeesh S; Kyo S; Banerjee PP
Cancer Res; 2006 Feb; 66(4):2107-15. PubMed ID: 16489011
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
5. [New insight into the mechanism of p53 inducing leukemia cell apoptosis].
Chen YZ; Wu Y; Liang M; Li NN; Zhang ZX; Lu LH
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):640-3. PubMed ID: 14761612
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways.
Tacheau C; Fontaine J; Loy J; Mauviel A; Verrecchia F
J Cell Physiol; 2008 Dec; 217(3):759-68. PubMed ID: 18668519
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta 1(TGF-beta1) down-regulates TNFalpha-induced RANTES production in rheumatoid synovial fibroblasts through NF-kappaB-mediated transcriptional repression.
Cho ML; Min SY; Chang SH; Kim KW; Heo SB; Lee SH; Park SH; Cho CS; Kim HY
Immunol Lett; 2006 Jun; 105(2):159-66. PubMed ID: 16564576
[TBL] [Abstract][Full Text] [Related]
8. Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.
Yang H; Kyo S; Takatura M; Sun L
Cell Growth Differ; 2001 Feb; 12(2):119-27. PubMed ID: 11243466
[TBL] [Abstract][Full Text] [Related]
9. Synergistic activation of extracellular signal-regulated kinase in human dermal fibroblasts by human telomerase reverse transcriptase and transforming growth factor-beta1.
Liu WR; Lu L; Rosenberg DS; Procaccini PS; Mustoe TA
J Surg Res; 2007 Dec; 143(2):415-21. PubMed ID: 17662305
[TBL] [Abstract][Full Text] [Related]
10. TGF-beta 1-induced PAI-1 expression is E box/USF-dependent and requires EGFR signaling.
Kutz SM; Higgins CE; Samarakoon R; Higgins SP; Allen RR; Qi L; Higgins PJ
Exp Cell Res; 2006 Apr; 312(7):1093-105. PubMed ID: 16457817
[TBL] [Abstract][Full Text] [Related]
11. Effects of transforming growth factor beta 1 on the growth of rhabdomyosarcoma cell line RD.
Ye L; Zhang HY; Wang H; Yang GH; Bu H; Zhang L; Wang SL
Chin Med J (Engl); 2005 Apr; 118(8):678-86. PubMed ID: 15899124
[TBL] [Abstract][Full Text] [Related]
12. Role of activator protein-1 on the effect of arginine-glycine-aspartic acid containing peptides on transforming growth factor-beta1 promoter activity.
Ruiz-Torres MP; Perez-Rivero G; Diez-Marques ML; Griera M; Ortega R; Rodriguez-Puyol M; Rodríguez-Puyol D
Int J Biochem Cell Biol; 2007; 39(1):133-45. PubMed ID: 16978906
[TBL] [Abstract][Full Text] [Related]
13. Transforming growth factor-beta1 and activin A generate antiproliferative signaling in thyroid cancer cells.
Matsuo SE; Leoni SG; Colquhoun A; Kimura ET
J Endocrinol; 2006 Jul; 190(1):141-50. PubMed ID: 16837618
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of estrogen receptor beta-mediated human telomerase reverse transcriptase gene transcription via the suppression of mitogen-activated protein kinase signaling plays an important role in 15-deoxy-Delta(12,14)-prostaglandin J(2)-induced apoptosis in cancer cells.
Kondoh K; Tsuji N; Asanuma K; Kobayashi D; Watanabe N
Exp Cell Res; 2007 Oct; 313(16):3486-96. PubMed ID: 17706193
[TBL] [Abstract][Full Text] [Related]
15. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
16. Activation of extracellular signal-regulated kinase by TGF-beta1 via TbetaRII and Smad7 dependent mechanisms in human bronchial epithelial BEP2D cells.
Huo YY; Hu YC; He XR; Wang Y; Song BQ; Zhou PK; Zhu MX; Li G; Wu DC
Cell Biol Toxicol; 2007 Mar; 23(2):113-28. PubMed ID: 17096210
[TBL] [Abstract][Full Text] [Related]
17. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
18. Induction of transforming growth factor-beta1 by basic fibroblast growth factor in rat C6 glioma cells and astrocytes is mediated by MEK/ERK signaling and AP-1 activation.
Dhandapani KM; Khan MM; Wade FM; Wakade C; Mahesh VB; Brann DW
J Neurosci Res; 2007 Apr; 85(5):1033-45. PubMed ID: 17335076
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.
He H; Xia HH; Wang JD; Gu Q; Lin MC; Zou B; Lam SK; Chan AO; Yuen MF; Kung HF; Wong BC
Cancer; 2006 Mar; 106(6):1243-9. PubMed ID: 16444744
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.
Moriai M; Tsuji N; Kobayashi D; Kuribayashi K; Watanabe N
Int J Oncol; 2009 May; 34(5):1363-72. PubMed ID: 19360348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
